These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 2145778)

  • 21. Atrial natriuretic peptide has dose-dependent, autonomically mediated effects on atrial refractoriness and repolarization in anesthetized dogs.
    Stambler BS; Guo GB
    J Cardiovasc Electrophysiol; 2005 Dec; 16(12):1341-7. PubMed ID: 16403067
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hemodynamic and renal effects of low-dose infusions of atrial peptide in awake dogs.
    Bie P; Wang BC; Leadley RJ; Goetz KL
    Am J Physiol; 1988 Feb; 254(2 Pt 2):R161-9. PubMed ID: 2964204
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Hemodynamic effects of infusions of alpha-human atrial natriuretic peptide in anesthetized dogs].
    Takeda S; Tomaru T; Inada Y
    Masui; 1992 Apr; 41(4):566-77. PubMed ID: 1533691
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Determinants of renal actions of atrial natriuretic peptide. Lack of effect of atrial natriuretic peptide on pressure-induced vasoconstriction.
    Hayashi K; Epstein M; Loutzenhiser R
    Circ Res; 1990 Jul; 67(1):1-10. PubMed ID: 2163775
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Atrial natriuretic peptide induces sustained natriuresis in conscious dogs.
    Mizelle HL; Hildebrandt DA; Gaillard CA; Brands MW; Montani JP; Smith MJ; Hall JE
    Am J Physiol; 1990 Jun; 258(6 Pt 2):R1445-52. PubMed ID: 2141770
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Atrial natriuretic peptide in patients with diabetes mellitus type I. Effects on systemic and renal hemodynamics and renal excretory function.
    Predel HG; Schulte-Vels O; Sorger M; Glänzer K; Geller C; Kramer HJ
    Am J Hypertens; 1990 Sep; 3(9):674-81. PubMed ID: 2145873
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vivo atrial peptide-venodilation: minimal potency relative to nitroglycerin in dogs.
    Holtz J; Stewart DJ; Elsner D; Bassenge E
    Life Sci; 1986 Dec; 39(23):2177-84. PubMed ID: 2946916
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regional hemodynamic effects of calcitonin gene-related peptide.
    Gardiner SM; Compton AM; Bennett T
    Am J Physiol; 1989 Feb; 256(2 Pt 2):R332-8. PubMed ID: 2521778
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cardiovascular and neurohormonal effects of atrial natriuretic peptide in conscious dogs with and without chronic left ventricular dysfunction.
    Carson P; Carlyle P; Rector TS; Cohn JN
    J Cardiovasc Pharmacol; 1990 Aug; 16(2):305-11. PubMed ID: 1697388
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of atrial natriuretic peptide on proximal epicardial coronary arteries and coronary blood flow in conscious dogs.
    Chu A; Cobb FR
    Circ Res; 1987 Oct; 61(4):485-91. PubMed ID: 2958167
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interaction of ANP with endothelin on cardiovascular, renal, and endocrine function.
    Ota K; Kimura T; Shoji M; Inoue M; Sato K; Ohta M; Yamamoto T; Tsunoda K; Abe K; Yoshinaga K
    Am J Physiol; 1992 Feb; 262(2 Pt 1):E135-41. PubMed ID: 1531732
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of ANP-(95-126) in dogs before and after induction of heart failure.
    Riegger GA; Elsner D; Forssmann WG; Kromer EP
    Am J Physiol; 1990 Dec; 259(6 Pt 2):H1643-8. PubMed ID: 2175565
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human atrial natriuretic peptide: plasma levels, hemodynamic, hormonal, and renal effects in patients with severe congestive heart failure.
    Riegger GA; Kromer EP; Kochsiek K
    J Cardiovasc Pharmacol; 1986; 8(6):1107-12. PubMed ID: 2434734
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Renal and hemodynamic effects of synthetic atrial natriuretic peptide in dogs with chronic renal failure.
    Tsuchiya K; Sanaka T; Ando A
    Nihon Jinzo Gakkai Shi; 1989 Feb; 31(2):151-7. PubMed ID: 2525634
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential haemodynamic effects of atrial natriuretic peptide (ANP) in normotensive and spontaneously hypertensive rats.
    Pettersson A; Ricksten SE; Hedner J; Hedner T
    Acta Physiol Scand; 1988 Oct; 134(2):247-51. PubMed ID: 2976237
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhanced alpha-adrenergic vasoconstriction by n-3 fatty acids in conscious dogs.
    Kenny D; Brooks HL; Warltier DC
    Am J Physiol; 1990 Jun; 258(6 Pt 2):H1660-7. PubMed ID: 1972867
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of converting-enzyme inhibitor on hemodynamic actions of ANP in renal hypertensive rats.
    Salom MG; Fenoy FJ; Inglés AC; Martínez L; Quesada T
    Am J Physiol; 1989 Aug; 257(2 Pt 2):R365-9. PubMed ID: 2527475
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hormone and hemodynamic responses to atrial natriuretic peptide in conscious sheep and effect of hemorrhage.
    Cameron VA; Espiner EA; Nicholls MG; Skidmore DS
    Endocrinology; 1988 Feb; 122(2):407-14. PubMed ID: 2827996
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of synthetic human atrial natriuretic peptide (hANP) in conscious dogs.
    Johannessen AC; Schütten HJ; Torp-Pedersen C; Warberg J; Bie P
    Acta Physiol Scand; 1986 Aug; 127(4):449-54. PubMed ID: 2944353
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Atriopeptin II lowers cardiac output in conscious sheep.
    Breuhaus BA; Saneii HH; Brandt MA; Chimoskey JE
    Am J Physiol; 1985 Dec; 249(6 Pt 2):R776-80. PubMed ID: 2933963
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.